A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome
Condition: Rett Syndrome Intervention: Genetic: NGN-401 Sponsor: Neurogene Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Children | Gene Therapy | Genetics | Neurology | Research | Rett Syndrome | Study